ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2015
A 3'-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.